On February 3, 2020 the HVTN 702 HIV vaccine efficacy trial in South Africa discontinued vaccinations because the interim review by the Data and Safety Monitoring Board reported that the vaccine candidate did not prevent HIV. There were no safety concerns. Dr Glenda Gray described the results available from the HVTN 702 Study.